Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
7.385 USD | +4.75% | +19.17% | +390.48% |
Kurzporträt
Mitarbeiterzahl: 42
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Paul-Peter Tak
CEO | Chief Executive Officer | 64 | 01.09.20 |
Founder | 66 | 01.01.02 | |
Charles Schoch
DFI | Director of Finance/CFO | 39 | - |
Seshu Tyagarajan
CTO | Chief Tech/Sci/R&D Officer | 57 | 02.03.22 |
Francesca Barone
CTO | Chief Tech/Sci/R&D Officer | 47 | 01.11.20 |
William Nichols
CTO | Chief Tech/Sci/R&D Officer | 55 | 12.09.22 |
Ileen B. Winick
HRO | Human Resources Officer | - | 01.01.21 |
Nathan Caffo
PRN | Corporate Officer/Principal | 55 | 01.09.20 |
Susan Stewart
LAW | General Counsel | 64 | 01.10.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph Papa
BRD | Director/Board Member | 68 | 08.08.22 |
Edward Benz
BRD | Director/Board Member | 78 | 01.09.17 |
Paul Manning
CHM | Chairman | 68 | 01.11.18 |
Gary Nabel
BRD | Director/Board Member | 70 | 08.08.22 |
Founder | 66 | 01.01.02 | |
Paul-Peter Tak
CEO | Chief Executive Officer | 64 | 01.09.20 |
Renee Gaeta
BRD | Director/Board Member | 42 | 08.08.22 |
Diem Nguyen
BRD | Director/Board Member | 52 | 15.07.21 |
Director/Board Member | 45 | 01.11.18 | |
Nicoletta Loggia
BRD | Director/Board Member | - | 07.06.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 29 470 076 | 19 157 342 ( 65,01 %) | 0 | 65,01 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+390.48% | 207 Mio. | |
-0.34% | 42.19 Mrd. | |
+44.30% | 40.15 Mrd. | |
-6.20% | 28.31 Mrd. | |
+5.44% | 24.63 Mrd. | |
-23.72% | 18.2 Mrd. | |
+26.77% | 12.01 Mrd. | |
-3.67% | 11.76 Mrd. | |
+14.46% | 10.4 Mrd. | |
-3.72% | 9.94 Mrd. |
- Börse
- Aktien
- A3CVW2 Aktie
- Unternehmen Candel Therapeutics, Inc.